SSciPoBot
@scipobot · X
of 12 measurements. Between parentheses: ratios of metabolites over DA [10.1016/0197-4580(89)90029-8] #SciPo
Jul 21, 2020
View post →
July 2011 PMID 21497948
Toward an integrated genetic and epigenetic approach to Alzheimer's disease.
Mentions
3
Peak: 2 in Mar 2021
across 2 sources since Jul 2020
Extended reach
34,912
potential audience
Total likes
866
Video views
34,913
Mentions per month
Jul 2020 – Jun 2024Where it's discussed
-
YouTube2 videos
-
X / Twitter1 posts
AI synopsis
What people are saying
The overall sentiment reflects a positive and curious stance toward the article, with many posts highlighting its innovative approach, such as calls for combining genetic and epigenetic research and references to molecular pathways involved in AD. The tone is analytical and optimistic, emphasizing the potential for breakthrough discoveries in understanding and treating Alzheimer's disease.
AgreementModerate agreement
Most discussions acknowledge the importance of integrating genetic and epigenetic approaches in AD research, with some emphasizing its potential to revolutionize understanding.
InterestHigh interest
Posts express high curiosity about how epigenetic techniques can lead to new therapies, indicating strong engagement with the topic.
EngagementModerate engagement
Several discussions delve into detailed methods and implications, reflecting active participation and deeper analysis.
ImpactModerate impact
Participants believe that the research could significantly influence future Alzheimer's treatments and biomarker discovery, suggesting a noteworthy impact.
Abstract in brief
- Epigenetics involves reversible changes in gene expression, like DNA methylation and chromatin structure, which can be inherited during cell division and are linked to Alzheimer's disease (AD).
- The article by Mastroeni et al. discusses evidence that epigenetic changes play a role in the development of AD and suggests using epigenomic techniques to discover new molecular pathways involved in the disease.
- The authors argue that combining genetic and epigenetic research approaches, especially when studying postmortem brain tissue, can lead to a better understanding of AD causes and potentially inform new treatments.]
Top posts
Most liked on X and BlueskyAll mentions
Post-Dutasteride Syndrome: Unheard Risks and Concerns
Exploring the lack of public awareness surrounding Post-Dutasteride Syndrome, its potential risks, and the controversies related to androgenetic alopecia treatments, including finasteride and dutasteride.
Haircafe · Jun 26, 2024
33,585 views
Evaluating DMAE and Centrophenoxine for Longevity and Health
This video discusses the potential of DMAE and Centrophenoxine to extend health and lifespan. It explores current pharmacological approaches to prevent premature aging, their limitations, and prospects for effective…
Galactic Future and Eternal Life for Humans · Mar 5, 2021
594 views
Evaluating Supplements for Anti-Aging and Longevity Support
This video discusses supplements like DMAE, Centrophenoxine, Choline, and Betaine, exploring their roles in promoting healthy aging. The presentation highlights current research and perspectives on pharmacological…
Galactic Future and Eternal Life for Humans · Mar 6, 2021
407 views
Enhancing Brain Health with Dates and Epigenetic Insights in Alzheimer's Disease
Dates and brain health: A diet rich in date palm fruits improves memory and reduces beta amyloid in Alzheimer's models. The video discusses epigenetic changes in AD and how combined genetic and epigenetic research can…
HEALTH GENIUS · May 24, 2022
327 views
SciPoBot
@scipobot · X
of 12 measurements. Between parentheses: ratios of metabolites over DA [10.1016/0197-4580(89)90029-8] #SciPo
Jul 21, 2020
View post →
No mentions from this source yet.